211 related articles for article (PubMed ID: 12792024)
1. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
Joet T; Eckstein-Ludwig U; Morin C; Krishna S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024
[TBL] [Abstract][Full Text] [Related]
2. The hexose transporter of Plasmodium falciparum is a worthy drug target.
Joët T; Krishna S
Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563
[TBL] [Abstract][Full Text] [Related]
3. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
[TBL] [Abstract][Full Text] [Related]
4. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).
Ionita M; Krishna S; Léo PM; Morin C; Patel AP
Bioorg Med Chem Lett; 2007 Sep; 17(17):4934-7. PubMed ID: 17587575
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor.
Joët T; Chotivanich K; Silamut K; Patel AP; Morin C; Krishna S
Biochem J; 2004 Aug; 381(Pt 3):905-9. PubMed ID: 15107012
[TBL] [Abstract][Full Text] [Related]
6. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.
Joët T; Holterman L; Stedman TT; Kocken CH; Van Der Wel A; Thomas AW; Krishna S
Biochem J; 2002 Dec; 368(Pt 3):923-9. PubMed ID: 12238947
[TBL] [Abstract][Full Text] [Related]
7. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality.
Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S
Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450
[TBL] [Abstract][Full Text] [Related]
8. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
Woodrow CJ; Burchmore RJ; Krishna S
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9931-6. PubMed ID: 10954735
[TBL] [Abstract][Full Text] [Related]
9. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives.
Fayolle M; Ionita M; Krishna S; Morin C; Patel AP
Bioorg Med Chem Lett; 2006 Mar; 16(5):1267-71. PubMed ID: 16361099
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hexose transport and abrogation of pH homeostasis in the intraerythrocytic malaria parasite by an O-3-hexose derivative.
Saliba KJ; Krishna S; Kirk K
FEBS Lett; 2004 Jul; 570(1-3):93-6. PubMed ID: 15251446
[TBL] [Abstract][Full Text] [Related]
11. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering.
Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW
PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153
[TBL] [Abstract][Full Text] [Related]
12. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT).
Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG
J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of
Won JY; Mazigo E; Cha SH; Han JH
Front Cell Infect Microbiol; 2023; 13():1321240. PubMed ID: 38282613
[No Abstract] [Full Text] [Related]
14. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds.
Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM
PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322
[TBL] [Abstract][Full Text] [Related]
15. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
Ellekvist P; Colding H
Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
[TBL] [Abstract][Full Text] [Related]
16. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.
Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766
[TBL] [Abstract][Full Text] [Related]
17. Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine.
Li Q; Manolescu A; Ritzel M; Yao S; Slugoski M; Young JD; Chen XZ; Cheeseman CI
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G236-42. PubMed ID: 15033637
[TBL] [Abstract][Full Text] [Related]
18. A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs.
Blume M; Hliscs M; Rodriguez-Contreras D; Sanchez M; Landfear S; Lucius R; Matuschewski K; Gupta N
FASEB J; 2011 Apr; 25(4):1218-29. PubMed ID: 21169382
[TBL] [Abstract][Full Text] [Related]
19. Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle.
Slavic K; Delves MJ; Prudêncio M; Talman AM; Straschil U; Derbyshire ET; Xu Z; Sinden RE; Mota MM; Morin C; Tewari R; Krishna S; Staines HM
Antimicrob Agents Chemother; 2011 Jun; 55(6):2824-30. PubMed ID: 21402842
[TBL] [Abstract][Full Text] [Related]
20. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter.
Woodrow CJ; Penny JI; Krishna S
J Biol Chem; 1999 Mar; 274(11):7272-7. PubMed ID: 10066789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
